Drug Shortage Report for APO-METHOTREXATE

Last updated on 2021-07-23 History
Report ID 54770
Drug Identification Number 02182963
Brand name APO-METHOTREXATE
Common or Proper name METHOTREXATE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) METHOTREXATE
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100's
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-12-30
Actual start date 2018-12-30
Estimated end date 2021-07-30
Actual end date 2021-07-21
Shortage status Resolved
Updated date 2021-07-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2021-07-23 French Compare
v12 2021-07-23 English Compare
v11 2021-07-15 French Compare
v10 2021-07-15 English Compare
v9 2021-06-09 French Compare
v8 2021-06-09 English Compare
v7 2021-03-12 French Compare
v6 2021-03-12 English Compare
v5 2021-03-12 French Compare
v4 2021-03-12 English Compare
v3 2018-12-31 English Compare
v2 2018-07-09 French Compare
v1 2018-07-09 English Compare

Showing 1 to 13 of 13